Emer Cooke
- 1 min read
- 2 chapters
Related on Lably
Through COVID-19 pandemic and Conflict of interest
Education
Cooke obtained a pharmacy degree at Trinity College, Dublin, Ireland in 1982, following which she remained at Trinity to complete Master's degrees in Science and in Business Administration
Sign in to keep reading
One more chapter is free with a Lably account.
Career
Starting in 1985, she held various positions in the pharmaceutical sector. From 1992 to 1995 and from 1996 to 1998 she worked for the lobbying organisation European Federation of Pharmaceutical Industries and Associations (EFPIA) as Manager of Scientific and Regulatory Affairs. She was Principal Administrator in the Pharmaceuticals Unit of the European Commission between 1998 and 2002, with responsibility for inspections, international activities and legislative initiatives. Ms Cooke joined EMA on 1 July 2002 where she worked first as Head of Inspections and then as Head of International Affairs. From 2021 she was appointed as Head of Regulation of Medicines and other Health Technologies with the World Health Organization (WHO).
EMA executive director
In November 2020 Cooke was appointed Executive Director of the EMA, also taking the position of chairperson at the International Coalition of Medicines Regulatory Authorities (ICMRA) at the same time. This was in the context of the midst of the COVID-19 pandemic.
On 16 March 2021, Cooke led an EMA press conference to inform about the ongoing investigation into reports of side-effects related to the Oxford–AstraZeneca COVID-19 vaccine. Cooke said the EMA remains "firmly convinced" that the vaccine benefits outweigh the risks of potential side effects.
Cooke's appointment was criticized in a session of the Austrian Parliament on 1 April 2021 when member of parliament Gerald Hauser claimed a potential conflict of interest between her allowing the vaccine in her regulatory function, while having worked for the very same industry as a lobbyist in the past.